About IMCoPharma
IMCoPharma is a company based in Ostrava (Czechia) founded in 2008 was acquired by Barentz in November 2019. IMCoPharma operates in a competitive market with competitors including Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.
- Headquarter Ostrava, Czechia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imcopharma As
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IMCoPharma
Detailed funding history for IMCoPharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IMCoPharma
IMCoPharma has secured backing from 1 investor. Prominent investors backing the company include Barentz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Barentz is recognized as a global specialty ingredients solution provider.
|
Locked | Locked | Locked |
Investor details for IMCoPharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IMCoPharma
Investment portfolio details for IMCoPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IMCoPharma
Detailed financials for IMCoPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imcopharma Comparisons
Peer comparison for IMCoPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IMCoPharma
IMCoPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
|
| Locked | Locked | Locked |
Manufacturer & supplier of generic pharmaceuticals
|
|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
Detailed competitors of IMCoPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imcopharma
Complete news archive for IMCoPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IMCoPharma
IMCoPharma was founded in 2008.
IMCoPharma is headquartered in Ostrava, Czechia. It is registered at Ostrava, Moravian-silesian Region, Czechia.
Ivan Mikes is the current CEO of IMCoPharma.
IMCoPharma was founded in 2008 in Ostrava, Czech Republic, within the pharmaceutical sector. Contract manufacturing services are provided for generic active pharmaceutical ingredients, medical devices, and food supplements. Additional offerings include technology transfer, research and formulation development, regulatory support, excipients, and natural products. Operations focus on supplying customers across the CIS region.
IMCoPharma's top competitors include Natco Pharma, Concord Biotech and Alembic Pharmaceuticals.
IMCoPharma has 1 investor. Key investors include Barentz.